Oncosil Medical Ltd has released a press release.
FDA IDE Approval
Filed with ASX ·
On 6ix: 6ix.com/news/fda-ide-approval
6ix hasn’t read this filing yet.
Story so far
Earlier from OncoSil Medical
- Regulatory Update June 2016
- OncoSil Medical Appoints Global Sales and Marketing Director
- Appendix 4C - Quarterly Cashflow
- Oncosils next generation delivery platform
- $10 Million Institutional Placement
Later from OncoSil Medical
- Hot Calibration Run of the OncoSil Device
- Appendix 4E - Preliminary final report 30 June 2016
- Receipt of $2.3m R & D Tax Incentive Refund
- Pancreatic cancer clinical study update
- Appendix 4C - Quarterly Cash Flow
Follow OncoSil Medical into a list and get an email when it puts out news.
Follow OncoSil Medical